Titlebook: Blood cells in nuclear medicine, part I; Cell kinetics and bi Max R. Hardeman,Yves Najean Book 1984 Martinus Nijhoff Publishers, The Hague

mentor

書目名稱Blood cells in nuclear medicine, part I影響因子(影響力)




書目名稱Blood cells in nuclear medicine, part I影響因子(影響力)學(xué)科排名




書目名稱Blood cells in nuclear medicine, part I網(wǎng)絡(luò)公開度




書目名稱Blood cells in nuclear medicine, part I網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Blood cells in nuclear medicine, part I被引頻次




書目名稱Blood cells in nuclear medicine, part I被引頻次學(xué)科排名




書目名稱Blood cells in nuclear medicine, part I年度引用




書目名稱Blood cells in nuclear medicine, part I年度引用學(xué)科排名




書目名稱Blood cells in nuclear medicine, part I讀者反饋




書目名稱Blood cells in nuclear medicine, part I讀者反饋學(xué)科排名

怕失去錢

Labelling Techniques of Granulocytes Platelets with 111In-Oxinateing can impede a sensitive detection due to a high background, in spite of the fact that the body will select the correct cell type from the labelled mixture by using specific cell functions in certain pathological processes (e.g. the chemotaxis of granulocytes into an abscess). It is clear that amo

Prostaglandins

Euthyroid

111Indium Loss from Platelets by in Vitro and Ex Vivo Manipulationitro uses of Indium labeled platelets derived from man and laboratory animals. Such labelled cells have been used for the determination of deep vein thrombosis (2) renal transplant rejection and associated problems (3) and the detection of thrombogenicity in prosthetic arterial graft materials (4).

RLS898

The Maturation of Megakaryocytes and their Precursorsts and megakaryoblasts and finally promegakaryocytes and megakaryocytes. Amplification in these cells follows distinct mechanisms. Cellular multiplication occurs only at the progenitor stage. In promegakaryoblasts and megakaryoblasts a second amplification process does not yield any increase in cell

Arresting

enlist

Evaluation of Models to Determine Platelet Life Span and Survival Curve Shape, and the effect of various diseases and therapies on platelet survival may be evaluated by the same technique. The recent introduction of .In-oxine as a cellular label allowing in vivo imaging of platelet distribution, has renewed interest in platelet kinetic studies (2,3).

larder

Comparison of Three Methods Evaluating Platelet Survival Time in Patients with Prosthetic Heart Valvn addition, 3 methods have been recommended for computing the mean survival time (1): the weighted mean of linear estimate or logarithmic estimate, the truncated exponential model and the gamma model. In our study these 2 later models and graphical method were used for evaluating platelet survival t

注視

Femish

Platelet Survival Time (51CR) and Platelet Production Time (Aspirin-Mda Method): A Simultaneous Eval (1). This property has been proposed to determine the platelet production time (PPT) after a single intake of aspirin (2). From a theoretical point of view, this non-isotopic method can constitute an alternative to the routine isotopic techniques for platelet kinetic measurements in stationary stat